Current Strategies of Secondary Prevention After a Cerebrovascular Event | Zendy

Wolfgang Lalouschek | Zendy; Wilfried Lang | Zendy; M Müllner | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Current Strategies of Secondary Prevention After a Cerebrovascular Event

Author(s) -

Wolfgang Lalouschek,

Wilfried Lang,

M Müllner

Publication year - 2001

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/hs1201.099891

Subject(s) - medicine , aspirin , clopidogrel , dipyridamole , stroke (engine) , atrial fibrillation , etiology , logistic regression , secondary prevention , cohort , odds ratio , cardiology , intensive care medicine , emergency medicine , mechanical engineering , engineering

Oral anticoagulation (OAC) and antiplatelet drugs are effective in the secondary prevention of ischemic cerebrovascular events. Only few data exist about the factors influencing the choice of a specific therapy for secondary prevention in patients with a recent stroke or transient ischemic attack (TIA).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research